UCSF Study Revisits First Clinical Trial to Treat Multiple Sclerosis Decades Later
More than two decades after a pivotal clinical trial of a drug was used to treat multiple sclerosis, researchers are reporting a surprising discovery: the people who received interferon in the trial, as opposed to a placebo, were only about half as likely to have died in years since.